Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database

Rhabdomyolysis is a syndrome potentially fatal and has been associated with selective serotonin reuptake inhibitors (SSRIs) treatment in a few case reports. Herein, we purpose to establish the correlation between SSRIs use and rhabdomyolysis using the U.S. Food and Drug Administration Adverse Event...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Lin, Yajing, Lin, Qing, Liang, Haiming, Cai, Weiming, Jiang, Dongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382477/
https://www.ncbi.nlm.nih.gov/pubmed/37507539
http://dx.doi.org/10.1038/s41598-023-39482-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382477/
https://www.ncbi.nlm.nih.gov/pubmed/37507539
http://dx.doi.org/10.1038/s41598-023-39482-y

Ejemplares similares